2019 – Page 57 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2019-05-31

Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele Announce Exclusive Worldwide License Agreement for the Treatment of MPS-I

Encouraging Clinical Data Generated from Ongoing Proof-of-Concept Study Conducted by the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget); Enrollment Expected to Complete in the First Half of 2020 Leverages Orchard’s Expertise in Treating Neurometabolic Diseases Using its Investigational Autologous Hematopoietic Stem Cell Gene Therapy Builds Upon Orchard / SR-Tiget Partnership to Develop Novel Gene Therapy Candidates Orchard Therapeutics, Fondazione

No Comments InGENE THERAPY RARE DISEASES

PIER MARIA FORNASARI
2019-05-31

Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease

Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious diseases, today announced a collaboration with Professor Melissa Little at the Murdoch Children’s Research Institute (“MCRI”), The Royal Children’s Hospital, Melbourne, Australia and Ton Rabelink at Universiteit Leiden (“LUMC”), Leiden, Netherlands. The project will expand the use of 3D bioprinted stem

No Comments InBIOPRINTING

PIER MARIA FORNASARI
2019-05-31

Key link discovered between tissue cell type and different forms of arthritis

Universities of Birmingham and Oxford brings us a step closer to developing targeted therapies for inflammatory diseases. The research team shows, for the first time, that different types of fibroblasts – the most common cells of connective tissue in animals – are organised in different layers in the joint and are responsible for two very

No Comments InAGEING

PIER MARIA FORNASARI
2019-05-31

Next-Generation drug targeting using natural Extracellular Vesicles

Utilising a cell’s own molecular delivery system could enable specific biomedical treatments In the world of drug delivery, getting an active compound to the right tissue or organ before the body’s defences break it down can make the difference between wellbeing and sickness, life and death. Clever capsules and coatings can boost the drug effect

No Comments InWELLNESS

PIER MARIA FORNASARI
2019-05-31

The Human Microbiome Project expands the toolbox for studying host and microbiome interactions

Results from three long-term studies following host and microbiome characteristics during pregnancy and preterm birth, inflammatory bowel disease, and prediabetes have expanded our understanding of how humans and microbes interact and the resulting consequences for our health. The studies were funded as part of a second phase of the National Institutes of Health’s Human Microbiome Project (HMP).

No Comments InMICROBIOME

PIER MARIA FORNASARI
2019-05-31

Owning Ethical Innovation: Claims about Commercial Wearable Brain Technologies

The wearable neurotechnology market targets consumers with promises of cognitive benefit and personal wellness. Scientific evidence is essential to substantiate claims about utility, safety, and efficacy and for informed choice and public trust. nhance your memory. Boost your mood. Lose weight more easily. Learn golf, CrossFit, or the clarinet faster. Or even: Regain more independence,

No Comments InWEARABLES

PIER MARIA FORNASARI
2019-05-31

NIH and radiology societies map path for translational research on AI in medical imaging

A new report, with contributions from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, provides a roadmap for translational research on artificial intelligence (AI) in medical imaging. The report, published in the May 28, 2019, Journal of the American College of Radiology, identifies research priorities that leverage

No Comments InARTIFICIAL INTELLIGENCE

PIER MARIA FORNASARI
2019-05-30

More Steps Per Day Tied to Lower Mortality in Older Women

Walking as few as 4400 steps per day may decrease the risk for all-cause mortality among older women, according to a study published online today in JAMA Internal Medicine and presented simultaneously at the American College of Sports Medicine (ACSM) 2019 Annual Meeting. The risk for death fell with increasing number of steps per day, and these benefits leveled

No Comments InWELLNESS

PIER MARIA FORNASARI
2019-05-30

Advanced Therapies Clinical Adoption by Cell and Gene Therapy Catapult

The UK ATTC Network is a world-first system of Advanced Therapy Treatment Centres (ATTCs), operating within the NHS framework and coordinated by CGT Catapult, that is addressing the unique and complex challenges of bringing pioneering advanced therapies to patients. The project has been funded by the Industrial Strategy Challenge Fund, part of the government’s modern Industrial Strategy,

No Comments InRESTORE LARGE SCALE RESEARCH INITIATIVE

PIER MARIA FORNASARI
2019-05-29

Most Cancer Drugs Approved Quickly Fail To Deliver On Promises, Studies Show

Cancer drugs are being approved by the FDA at an alarmingly fast rate after preliminary studies show encouraging results. However, after more careful follow-up trials were done, most of these drugs did not show any clear benefits. Cancer drugs are usually granted accelerated approval in the hopes of providing patients faster access to medicine that

No Comments InWELLNESS

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Archives: 2019-05-31

Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele Announce Exclusive Worldwide License Agreement for the Treatment of MPS-I

Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease

Key link discovered between tissue cell type and different forms of arthritis

Next-Generation drug targeting using natural Extracellular Vesicles

The Human Microbiome Project expands the toolbox for studying host and microbiome interactions

Owning Ethical Innovation: Claims about Commercial Wearable Brain Technologies

NIH and radiology societies map path for translational research on AI in medical imaging

More Steps Per Day Tied to Lower Mortality in Older Women

Advanced Therapies Clinical Adoption by Cell and Gene Therapy Catapult

Most Cancer Drugs Approved Quickly Fail To Deliver On Promises, Studies Show